MAPT and Alzheimer disease: The severity of tau pathology in AD, is usually assessed using Braak staging, a neuropathological classification that traces the spread of neurofibrillary tangles from the transentorhinal region in early stages (I–II), to the limbic areas (III–IV), and finally to the neocortex in the most advanced stages (V–VI) [86].